Role of ethnicity and residency in active tuberculosis in Karakalpakstan: study protocol of a matched case-control study.

Introduction: Uzbekistan is one of the 30 countries with the highest tuberculosis (TB) morbidity, accounting for 87% of all cases globally. The incidence of TB in the Republic of Karakalpakstan (RK) remains consistently high in comparison with other regions of Uzbekistan. The incidence rates of TB strongly differ even among the regions within RK.

Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.

Background: In the pandemic time, many low- and middle-income countries are experiencing restricted access to COVID-19 vaccines. Access to imported vaccines or ways to produce them locally became the principal source of hope for these countries. But developing a strategy for success in obtaining and allocating vaccines was not easy task.

Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005-2020), Republic of Karakalpakstan, Uzbekistan.

Tuberculosis (TB) remains a public health burden in the Republic of Karakalpakstan, Uzbekistan. This region-wide retrospective cohort study reports the treatment outcomes of patients registered in the TB electronic register and treated with first-line drugs in the TB Programme of the Republic of Karakalpakstan from 2005-2020 and factors associated with unfavourable outcomes. Among 35,122 registered patients, 24,394 (69%) patients were adults, 2339 (7%) were children, 18,032 (51%) were male and 19,774 (68%) lived in rural areas.

Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.

Background In the pandemic time, many low- and middle-income countries are experiencing restricted access to COVID-19 vaccines. An access to imported vaccines or ways to produce them locally becomes the principal source of hope. But developing a strategy for success in obtaining and allocating vaccines is not easy task.

[Clinical observation of the successful outcome of balloon angioplasty of the right coronary artery of the heart fourteen years after the procedure in a patient with chronic ischemic heart disease].

The method of isolated angioplasty has long ceased to be the leading interventional method of treating ischemic heart disease. This clinical case study describes an example of a good fourteen-year result of balloon angioplasty in a patient with stable angina pectoris. A specific example demonstrates the excellent super-long-distance result of such a procedure on the right coronary artery using an additional method of intravascular vizualization - optical coherent tomography.